Cargando…
Innovative Immunization Strategies for Antivenom Development
Snakes, scorpions, and spiders are venomous animals that pose a threat to human health, and severe envenomings from the bites or stings of these animals must be treated with antivenom. Current antivenoms are based on plasma-derived immunoglobulins or immunoglobulin fragments from hyper-immunized ani...
Autores principales: | Bermúdez-Méndez, Erick, Fuglsang-Madsen, Albert, Føns, Sofie, Lomonte, Bruno, Gutiérrez, José María, Laustsen, Andreas Hougaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265855/ https://www.ncbi.nlm.nih.gov/pubmed/30400220 http://dx.doi.org/10.3390/toxins10110452 |
Ejemplares similares
-
Integrating Engineering, Manufacturing, and Regulatory Considerations in the Development of Novel Antivenoms
por: Laustsen, Andreas Hougaard, et al.
Publicado: (2018) -
Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020) -
Biotechnological Trends in Spider and Scorpion Antivenom Development
por: Laustsen, Andreas Hougaard, et al.
Publicado: (2016) -
Toxin Neutralization Using Alternative Binding Proteins
por: Jenkins, Timothy Patrick, et al.
Publicado: (2019) -
Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims †
por: Kini, R. Manjunatha, et al.
Publicado: (2018)